Strategic and operationally oriented general counsel and executive team member who combines business savvy and global P&L experience with battle-tested legal skills. • High-impact executive with a record of success managing existential threats, spearheading strategic alternatives, and leading enterprise-wide communications. • Repeatedly tapped to lead non-legal functions, including patient advocacy, regulatory affairs, clinical affairs, quality assurance, and corporate marketing.• Excels at negotiating and navigating and resolving complex legal matters, including litigation, intellectual property strategy and regulatory and compliance issues, government investigations, employment law, and SEC matters.• Expertise managing M&A negotiations and due diligence and integration for multibillion dollars in acquisitions of public and private concerns and structuring licensing and manufacturing agreements. • Significant boardroom presence, advising on strategic business and legal issues, managing board meeting agendas, and counseling on governance issues. • Brings expertise managing across all aspects of the highly regulated life science industry, including branded and generic pharmaceuticals, biotech, diagnostics, and medical technology, working with companies in pre-clinical, clinical, and commercialization phases.